Oncomine

With more than 12,000 academic research users and 15 of the top 20 oncology drug development companies, Oncomine has become a standard research platform within the cancer genomics community. Compendia’s ongoing commitment to cancer genomics researchers is demonstrated by its continuous investment in and improvement of the Oncomine Platform, providing more data, more metadata, more different types of genomic and molecular data, more analyses and more powerful visualizations.

Oncomine-based discovery and validation strategies integrate gene expression data and signatures with additional genomics data types including DNA copy number data and third party annotations from a variety of public resources.

Proxeon

Proxeon is an established provider of innovative products focused towards the proteomics market. Taking advantage of core internal competencies, Proxeon develops products and solutions that fulfil the need to enhance performance, solve technical challenges, and thereby accelerate the proteomics workflow, from sample preparation through to data interpretation. In the field of mass spectrometry, Proxeon's nano ES ion sources are used in over 700 laboratories, and the company is one of the world's largest suppliers of nano ES emitters. The company's EASY-nLC™ for nanoscale chromatography in LC-MS is the system of choice for several major MS suppliers. ProteinCenter™, a unique tool for rapid data interpretation after protein identification by conventional search engines, is being used increasingly in proteomic laboratories. The company's products are used in leading academic and industrial research laboratories throughout the world. Established in 2002, Proxeon is headquartered in Odense, Denmark and has sales operations in the USA and Europe.